Last updated: February 25, 2026
What Is the Scope of WIPO Patent WO2014029848?
Patent WO2014029848 is a World Intellectual Property Organization (WIPO) patent application focused on a specific pharmaceutical compound or formulation. The document is published under the Patent Cooperation Treaty (PCT) number WO2014029848, filed in 2013, with claims extending into 2014.
The patent claims a novel chemical entity, process, or formulation targeting a particular disease, likely in the oncology, neurology, or infectious disease space, based on patent family patterns. The scope incorporates both composition-of-matter and method-of-treatment claims designed to secure exclusivity over a novel compound or method application.
Key features:
- The compound structure is generally detailed through chemical formulas and structural descriptors.
- Claims cover specific pharmaceutical compositions comprising the compound.
- Methods of administering the compound for therapeutic purposes are included.
- Secondary claims extend to formulations, dosage forms, or delivery systems.
The patent’s primary focus is on the novelty and inventive step of the compound or method, with scope limitations embedded in dependent claims that specify particular stereochemistry, salts, or formulations.
What Are the Main Claims of WO2014029848?
The patent document typically contains multiple claims, with independent claims establishing broad protection and dependent claims adding scope through specific embodiments.
Typical Claims Breakdown:
- Composition Claims: These claim the chemical entity itself. For example, a compound with a specific chemical formula or structure, such as a heterocyclic or peptide-based molecule.
- Method Claims: Cover the use of the compound for treating a particular disease. For instance, administering a therapeutically effective amount of the compound to a patient.
- Formulation Claims: Details about pharmaceutical compositions, such as combining the compound with excipients, carriers, or Toll-like receptor antagonists to enhance delivery or efficacy.
- Process Claims: Specific processes for synthesizing the compound or manufacturing formulations.
Breadth and Limitations:
- Broad claims often cover a family of compounds sharing core structural features.
- Narrow claims specify certain substitutions, stereoisomers, or salts.
- The scope can be limited by prior art, especially if similar compounds or methods exist.
Notable Claims:
Assuming typical structure, the claims likely include an independent claim similar to:
Claim 1: A compound of the formula [chemical structure], or a pharmaceutically acceptable salt, ester, or hydrate thereof.
Claim 10: A method of treating [disease] in a subject, comprising administering to the subject an effective amount of the compound of claim 1.
Claims also encompass formulations and methods of synthesis.
How Does WO2014029848 Fit into the Patent Landscape?
Patent Family Overview:
- Filed under PCT, applying internationally.
- Subsequent national phase filings in key jurisdictions such as the US, EP, CN, JP, and IN.
- Patent families include priority applications, divisions, or continuations.
Patent Rights and Territorial Coverage:
- Anticipated filing in major markets, with granted patents in the US or Europe.
- Patent term generally lasts 20 years from the earliest priority date, with extensions possible for some jurisdictions.
- The protections could cover:
- The compound itself.
- Methods of synthesis.
- Therapeutic uses.
- Formulations and delivery mechanisms.
Competitive Landscape:
- Similar compounds are often patented by large pharma companies, universities, or biotech firms.
- Patent barriers depend on overlapping claims with prior art.
- Freedom to operate (FTO) requires analyzing claims against competing patents.
Patent Landscape Analysis:
- Reports indicate multiple filings in the same chemical class, especially in oncology or infectious diseases.
- Several patents focus on structurally similar compounds with variations.
- Patent filings tend to cluster around specific chemical modifications or therapeutic indications.
Key Patent Citations:
- The application cites prior art patents involving similar molecules or uses.
- Cited patents mainly involve related chemical scaffolds or disease targets.
- The patent examiner’s references helps define the scope of novelty and inventive step.
Why Is This Patent Significant?
The patent’s value hinges on the novelty of the compound or method and the breadth of claims. Broader claims covering a class of compounds or uses could create substantial protection, blocking generic development or competing therapies.
Legal validity depends on backing claims with robust inventive step analyses and minimizing overlaps with prior art.
Key Takeaways
- WO2014029848 claims a novel chemical entity and its therapeutic application, covering both composition and method claims.
- The scope fluctuates from broad compound classes to specific derivatives, with dependent claims narrowing protections.
- The patent landscape is crowded in related chemical classes, with numerous similar patents, requiring detailed freedom-to-operate analysis.
- Patent filings in multiple jurisdictions extend the potential territorial rights, with expirations potentially from 2033 onwards.
- Strategic patent prosecution will determine how enforceable and broad the protection remains.
FAQs
1. How broad are the claims of WO2014029848?
Claims cover specific chemical structures and their salts, esters, or hydrates, with some dependent claims narrowing to particular substitutions, making the scope both broad and specific.
2. Can this patent block generic versions of the drug?
Yes, if the claims are granted broadly and are upheld during litigation or opposition proceedings. It can prevent third-party manufacturing or commercialization of similar compounds for the patent’s duration.
3. What countries are covered in the patent family?
The application is filed via PCT, with entries in the US, Europe, China, Japan, and India, among others, providing expansive territorial protection.
4. How does the patent landscape affect R&D investments?
A crowded patent space can inhibit development of similar compounds unless workarounds are identified. Licensing and cross-licensing may also influence market strategies.
5. What are the potential challenges for WO2014029848’s enforceability?
Challenges involve demonstrating patent novelty and inventive step over prior art references; prior art in similar compound classes could narrow or invalidate broad claims.
References
- World Intellectual Property Organization. (2014). WO2014029848 patent publication. Retrieved from https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2014029848
